MEC Plus Full List View

By pinki@katapult.biz / February 16, 2025

Updates in Locally Advanced Unresectable (Stage III) NSCLC

Updates in Locally Advanced Unresectable (Stage III) NSCLC

Jorge Nieva, MD

Advances in Limited and Extensive Stage Small Cell Lung Cancer

Advances in Limited and Extensive Stage Small Cell Lung Cancer

Jyoti Malhotra, MD, MPH

Updates in NSCLC Targeted Therapy

Updates in NSCLC Targeted Therapy

Jonathan W. Riess, MD, MS

Updates in Immunotherapy for Metastatic Lung Cancer

Updates in Immunotherapy for Metastatic Lung Cancer

Erminia Massarelli, MD, PhD, MS

New Developments in Esophageal and Gastric Cancer

New Developments in Esophageal and Gastric Cancer

Sandra Algaze, MD

Recent Advances in Colorectal Cancer

Recent Advances in Colorectal Cancer

Heinz-Josef Lenz, MD, FACP

Updates in the Management of Pancreatic Cancer

Updates in the Management of Pancreatic Cancer

Vincent Chung, MD, FACP

Advances in Cellular Therapies for Cancer

Advances in Cellular Therapies for Cancer

Mohamed Abou-el-Enein, MD, PhD, MSPH

Advances in Non-PD(L)1 Immunotherapies in Solid Tumors

Advances in Non-PD(L)1 Immunotherapies in Solid Tumors

Miguel Villalona-Calero, MD

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

David Gandara, MD

Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

S. Percy Ivy, MD

Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?

Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?

Paul Frankel, PhD

Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory

Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory

Timothy Synold, PharmD

Clinical Update: Sickle Cell Disease and CRISPR

Clinical Update: Sickle Cell Disease and CRISPR

Sophia Z. Humphreys, PharmD, MHA, BCBBS

Clinical Update: Solid Organ Tumors

Clinical Update: Solid Organ Tumors

Osler Andres, PharmD, BCOP, BCSCP

Development of Pharmacy-Led Ambulatory Infusion Services (Part 3)

Development of Pharmacy-Led Ambulatory Infusion Services (Part 3)

Melissa Casey, PharmD

Development of Pharmacy-Led Ambulatory Infusion Services (Part 2)

Development of Pharmacy-Led Ambulatory Infusion Services (Part 2)

Tamera L. Boeshans, BSPharm

Development of Pharmacy-Led Ambulatory Infusion Services (Part 1)

Development of Pharmacy-Led Ambulatory Infusion Services (Part 1)

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Patient Centered Pharmaceutical Care in Community Setting

Patient Centered Pharmaceutical Care in Community Setting

Melissa Russo, PharmD

Artificial Intelligence (AI): How Can This Technology Supplement the Advanced Role of the Pharmacist?

Artificial Intelligence (AI): How Can This Technology Supplement the Advanced Role of the Pharmacist?

Ashish Advani, PharmD

Clinical Update: Malignant Hematology

Clinical Update: Malignant Hematology

Atis Barzdins, MD

White Bagging & The Movement for Policy Development

White Bagging & The Movement for Policy Development

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Clinical and Practice Considerations in the Management of Iron Deficiency Anemia

Clinical and Practice Considerations in the Management of Iron Deficiency Anemia

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

PD-1 Inhibitor Update

PD-1 Inhibitor Update

Sophia Z. Humphreys, PharmD, MHA, BCBBS

Policy Update - Financial Survival: It’s not Easy Being Green!!

Policy Update - Financial Survival: It’s not Easy Being Green!!

Bonnie Kirschenbaum, BScPharm, MS, FASHP, FCSHP

Minimizing Waste by Maximizing BUDs: Immediate Use Compounding for Biologics

Minimizing Waste by Maximizing BUDs: Immediate Use Compounding for Biologics

Kerrie B. Lee, PharmD, BCSCP

Clinical Update: Biosimilars to Adalimumab

Clinical Update: Biosimilars to Adalimumab

Johnny Chang, PharmD, BCPS, CSP

The Art and the Science of Formulary Management | Acute to Ambulatory Strategies

The Art and the Science of Formulary Management | Acute to Ambulatory Strategies

Catherine Brown, PharmD, MSM, BCPS & Steve Pickette, PharmD, BCPS

Clinical Update: Cell and Gene Therapy, the Future of Medicine

Clinical Update: Cell and Gene Therapy, the Future of Medicine

Sophia Z. Humphreys, PharmD, MHA, BCBBS

$Sequencing Therapy in Relapsed/Refractory Myeloma Patients$

Sequencing Therapy in Relapsed/Refractory Myeloma Patients

Craig Emmitt Cole, MD